In summary, ACSL4-dependent ferroptosis occurs both in tumors with high ACSL4 expression (e.g., sorafenib-treated hepatocellular carcinoma) and in pathological processes like IRI affecting other tissues (e.g., transplantation). This evidence concerns the gene ACSL4 and hepatocellular carcinoma.